Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | THRA | P10827 | 2/20 | 0.35 |
| ▸ | THRB | P10828 | 2/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30800827 | 0.98 | LTA4H (0.43) | LTA4HL3MBTL1MEN1KMT2ATDP1 | |
| SCHEMBL8432395 | 0.98 | LTA4H (0.42) | LTA4HL3MBTL1MEN1KMT2ATDP1 | |
| SCHEMBL9275922 | 0.95 | LTA4H (0.44) | LTA4HL3MBTL1MEN1KMT2ATDP1 | |
| SCHEMBL14759523 | 0.95 | LTA4H (0.44) | LTA4HL3MBTL1MEN1KMT2ATDP1 | |
| SCHEMBL7828731 | 0.93 | LTA4H (0.38) | LTA4HL3MBTL1MEN1KMT2ATDP1 | |
| SCHEMBL3127470 | 0.93 | TSHR (0.42) | LTA4HL3MBTL1MEN1KMT2ATDP1 | |
| SCHEMBL4917509 | 0.91 | TSHR (0.39) | LTA4HL3MBTL1MEN1KMT2ATDP1 | |
| SCHEMBL8972630 | 0.86 | THRB (0.40) | LTA4HMEN1KMT2ATDP1MAPT | |
| SCHEMBL4175721 | 0.86 | THRB (0.40) | LTA4HMEN1KMT2ATDP1MAPT | |
| SCHEMBL10378875 | 0.86 | THRB (0.40) | LTA4HMEN1KMT2ATDP1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 310 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3221307-B1 | NOVEL 1,3,5 -TRIAZINE BASED PI3K INHIBITORS AS ANTICANCER AGENTS AND A PROCESS FOR THE PREPARATION THEREOF | COUNCIL SCIENT IND RES (IN) | 2019-07-24 | — | — | EP | claimed |
| US-9951040-B2 | 1,3,5 -triazine based PI3K inhibitors as anticancer agents and a process for the preparation thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2018-04-24 | — | — | US | claimed |
| US-20170342049-A1 | NOVEL 1,3,5 -TRIAZINE BASED PI3K INHIBITORS AS ANTICANCER AGENTS AND A PROCESS FOR THE PREPARATION THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2017-11-30 | — | — | US | claimed |
| EP-3221307-A1 | NOVEL 1,3,5 -TRIAZINE BASED PI3K INHIBITORS AS ANTICANCER AGENTS AND A PROCESS FOR THE PREPARATION THEREOF | Council of Scientific and Industrial Research (IN) | 2017-09-27 | — | — | EP | claimed |
| WO-2016079760-A1 | NOVEL 1,3,5 -TRIAZINE BASED PI3K INHIBITORS AS ANTICANCER AGENTS AND A PROCESS FOR THE PREPARATION THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-05-26 | — | — | WO | claimed |
| US-9184428-B2 | Non-aqueous electrolytes for lithium ion batteries | UCHICAGO ARGONNE LLC (US) | 2015-11-10 | — | — | US | claimed |
| US-20150148464-A1 | FLAME RETARDANT COMPOSITIONS OF PHOSPHINIC ACID SALTS AND NITROXYL DERIVATIVES | BASF SE (DE) | 2015-05-28 | — | — | US | claimed |
| US-9012096-B2 | Long life lithium batteries with stabilized electrodes | UCHICAGO ARGONNE, LLC (US) | 2015-04-21 | — | — | US | claimed |
| CN-103025812-B | Phosphinic acid hydrazide flame retardant compositions | BASF SE | 2014-08-13 | — | — | CN | claimed |
| CN-102471533-B | Phenylphosphonate flame retardant compositions | BASF SE | 2014-07-02 | — | — | CN | claimed |
| WO-2005066290-A1 | INK JET INK COMPOSITION | EASTMAN KODAK COMPANY (US) | 2005-07-21 | — | — | WO | claimed |
| US-20050134665-A1 | Ink jet ink composition | EASTMAN KODAK COMPANY | 2005-06-23 | — | — | US | claimed |
| EP-1201720-B1 | Printing fluid additives promoting overcoat adhesion | HEWLETT PACKARD CO (US) | 2004-09-15 | — | — | EP | claimed |
| US-6610412-B2 | Clear protective thermal transfer overcoating and acrylic polymer compatibilizer; computer prints | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2003-08-26 | — | — | US | claimed |
| US-20030119973-A1 | Printing fluid additives promoting overcoat adhesion | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2003-06-26 | — | — | US | claimed |
| US-6417249-B1 | INK JET PRINTING INK FOR COLOR VEHICLES, CORE/SHELL BINDERS, SMUDGE PROOF | HEWLETT-PACKARD COMPANY | 2002-07-09 | — | — | US | claimed |
| EP-1201720-A1 | Printing fluid additives promoting overcoat adhesion | Hewlett-Packard Company (US) | 2002-05-02 | — | — | EP | claimed |
| US-6248805-B1 | THERMAL INK JET PRNTING | HEWLETT-PACKARD COMPANY | 2001-06-19 | — | — | US | claimed |
| US-6057384-A | VEHICLE AND COLORANT ASSOCIATED WITH A PRIMER CORE/SHELL POLYMER; DURABLR SMEAR-FAST FILM | HEWLETT-PACKARD COMPANY (US) | 2000-05-02 | — | — | US | claimed |
| US-5990202-A | DURABLE, SMEAR-FAST INK FILMS COMPRISING DUAL ENCAPSULATED COLORANT; A PRIMER CORE/SHELL POLYMER COATING A COLORANT (ADHESION) AND AN EXTERIOR CORE/SHELL POLYMER COATING FOR DURABILITY | HEWLETT-PACKARD COMPANY (US) | 1999-11-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170342049-A1 | NOVEL 1,3,5 -TRIAZINE BASED PI3K INHIBITORS AS ANTICANCER AGENTS AND A PROCESS FOR THE PREPARATION THEREOF | PIK3CA, PIK3R5, PIK3CD | LTA4H 3545/4885L3MBTL1 4391/4885MEN1 1578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.